Run time: 53m

  0      0

On-Demand eCasts

21EL-612 On-Demand eCast: To Ignore or Not to Ignore? Transfusing Patients with Multiple Alloantibodies

Expiration Date: Mar 10, 2024

Credits: None available.


Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, March 10, 2021
Program Number: 21EL-612

Educational Track: Technical/Clinical
Topics: Antibody Identification, Complications, Immunohematology, Patient Transfusion, Transfusion Process
Intended Audience: Directors, Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Basic, Intermediate

(titles and affiliations at the time of the live program)
Director/Moderator: Lisa M. Shave MS, MLS(ASCP)CMSBBCM, Medical Laboratory Technology Program Coordinator & Professor, MLT Coordinator at Mercer County Community College, West Windsor, NJ, Blood Bank Medical Laboratory Scientist, MLS at Pennsylvania Hospital, Philadelphia, PA
Speakers: Jeanne Hendrickson, MD, Professor of Laboratory Medicine; Medical Director of Apheresis Service/Laboratory Medicine; Associate Director, Transfusion Medicine Service, Yale University/Yale New Haven Hospital, New Haven, CT; Rebecca Ross, MA Ed, BS, MT (ASCP), SBB, Manager, Yale New Haven Blood Banks, Yale New Haven Hospital, New Haven, CT; Sean Stowell, MD, Associate Professor, Department of Pathology, Harvard University, Brigham and Women’s Hospital, Boston, MA

Program Description
Red cell alloimmunization may occur during or after blood transfusions, evoking the immune system to produce alloantibodies. This program focuses on the induced response and reviews clinically significant versus clinically insignificant alloantibodies in patients who receive multiple transfusions with an emphasis on case examples.

Learning Objectives
After participating in this educational activity, participants should be able to:

  • Describe clinically significant antibodies.
  • Define antibodies that are clinically insignificant.
  • Discuss strategies to work through which antibodies may be transfused against in emergency situations.

How to Claim Continuing Education Credit

  • Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
  • Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Director & Moderator(s):

  • Lisa Shave, MS, MLS(ASCP)SBB, Medical Laboratory Scientist, Medical Laboratory Technology Program Coordinator, Pennsylvania Hospital, Mercer County Community College


  • Dr. Sean Stowell, MD, PhD, Brigham and Women's Hospital Apheresis Service Associate Medical Director, Brigham and Women's Hospital
  • Dr. Jeanne Hendrickson, MD, Yale University
  • Rebecca Ross, MA Ed, BS, MT (ASCP), SBB, Manager, Yale New Haven Blood Banks, Yale New Haven Hospital


  • 1.00 - General Continuing Education (GEN)
  • 1.00 - Florida Lab Personnel (FLP)
  • 1.00 - California Lab Personnel (CLP)

You must be logged in and own this session in order to post comments.